17 OHPC for Pregnancy

Winfred L. Wiser Hospital, Jackson, MS
Pregnancy17 OHPC - Drug
18 - 45

Study Summary

This trial will test if 17 OHPC given to preeclamptic mothers before 34 weeks improves mother and baby outcomes.

Eligible Conditions
  • Pregnancy

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
Phase 2

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Until delivery

Improvement of maternal and perinatal outcomes
Baseline until delivery
Assessment of Placental Abruption
Change from Baseline until delivery
Assessment of Acute Kidney Injury
Assessment of Biomarkers
Assessment of DIC
Assessment of Pulmonary edema
Assessment of laboratory results
Assessment of neurological events
Assessment of APGAR score
Assessment of Infant Weight
Assessment of Interventricular hemorrhage
Assessment of NICU stays
Assessment of Necrotizing enterocolitis (NEC)
Assessment of Respiratory Distress Syndrome
Until delivery
Change is being assessed in Maternal Outcomes

Trial Safety

Phase-Based Safety

2 of 3
This is further along than 68% of similar trials

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.

Trial Design

2 Treatment Groups

1 of 2
1 of 2

Active Control

Experimental Treatment

60 Total Participants · 2 Treatment Groups

Primary Treatment: 17 OHPC · No Placebo Group · Phase 2

Experimental Group · 1 Intervention: 17 OHPC · Intervention Types: Drug
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: until delivery

Who is running the clinical trial?

Babbette LamarcaLead Sponsor
Babbette LaMarca, PhDPrincipal InvestigatorUniversity of Missisippi Medical Center

Eligibility Criteria

Age 18 - 45 · Female Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Is this study enrolling seniors aged 55 and above?

"Based on the research criteria, only people between 18 and 45 years old are eligible to partake in this medical study." - Anonymous Online Contributor

Unverified Answer

How is 17 OHPC typically employed therapeutically?

"17 OHPC is a viable solution for the prevention or management of uterine haemorrhage, preterm birth, and premature deliveries." - Anonymous Online Contributor

Unverified Answer

What type of participants is most suitable for this medical research?

"To qualify for this medical experiment, a patient should have pre-eclampsia and be between 18 to 45 years old. Approximately 60 people are being sought after." - Anonymous Online Contributor

Unverified Answer

Is 17 OHPC detrimental to human health?

"While clinical trials have indicated that 17 OHPC is relatively safe, the lack of data supporting efficacy warrants a score of 2." - Anonymous Online Contributor

Unverified Answer

How many participants are currently partaking in this research?

"Indeed, the program is actively enrolling patients as indicated on clinicaltrials.gov. This project was initially published on May 22nd 2017 and most recently amended on January 5th 2022; it seeks to recruit 60 individuals from a single site." - Anonymous Online Contributor

Unverified Answer

Are there presently any openings for study participants?

"According to information on clinicaltrials.gov, enrollment is currently open for this trial which was initially made available on May 22nd 2017 and recently modified on January 5th 2022." - Anonymous Online Contributor

Unverified Answer

Are there other investigations that have focused on 17 OHPC?

"Currently, there are two active clinical trials involving 17 OHPC and neither of them is in Phase 3. These studies can be found in Jackson, Mississippi as well as one other location across the nation." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.